Cargando…

PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation

Multiple Sclerosis (MS) is a chronic autoimmune inflammatory disorder of the central nervous system (CNS). Current therapies mainly target inflammatory processes during acute stages, but effective treatments for progressive MS are limited. In this context, astrocytes have gained increasing attention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linnerbauer, Mathias, Beyer, Tobias, Nirschl, Lucy, Farrenkopf, Daniel, Lößlein, Lena, Vandrey, Oliver, Peter, Anne, Tsaktanis, Thanos, Kebir, Hania, Laplaud, David, Oellinger, Rupert, Engleitner, Thomas, Alvarez, Jorge Ivan, Rad, Roland, Korn, Thomas, Hemmer, Bernhard, Quintana, Francisco J., Rothhammer, Veit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492803/ https://www.ncbi.nlm.nih.gov/pubmed/37689786 http://dx.doi.org/10.1038/s41467-023-40982-8

Ejemplares similares

Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation
por: Linnerbauer, Mathias, et al.
Publicado: (2022)

Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing–remitting multiple sclerosis
por: Tsaktanis, Thanos, et al.
Publicado: (2023)

Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammation
por: Linnerbauer, Mathias, et al.
Publicado: (2022)

Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS
por: Tsaktanis, Thanos, et al.
Publicado: (2020)

The Aryl Hydrocarbon Receptor–Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis
por: Cirac, Ana, et al.
Publicado: (2021)

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult
por: Linnerbauer, Mathias, et al.
Publicado: (2020)

The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes
por: Bertram, Dominic, et al.
Publicado: (2023)

Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
por: Rothhammer, Veit, et al.
Publicado: (2011)

Using positive deviance (PD) to reduce antibiotic resistant organisms: the Canadian PD project
por: Reason, P, et al.
Publicado: (2011)

IL-24 intrinsically regulates Th17 cell pathogenicity in mice
por: Sie, Christopher, et al.
Publicado: (2022)

Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica
por: Kalluri, Sudhakar Reddy, et al.
Publicado: (2011)

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
por: Claaß, Luise Victoria, et al.
Publicado: (2022)

Paucity of PD-L1 Expression in Prostate Cancer: Innate and Adaptive Immune Resistance
por: Martin, Allison M., et al.
Publicado: (2015)

What does PD-L1 positive or negative mean?
por: Ribas, Antoni, et al.
Publicado: (2016)

PD-1 Controls Follicular T Helper Cell Positioning and Function
por: Shi, Jingwen, et al.
Publicado: (2018)

Depletion of PD-1-positive cells ameliorates autoimmune disease
por: Zhao, Peng, et al.
Publicado: (2019)

Cutaneous metastasis of PD-L1 positive ovarian carcinoma
por: Hastings, Victoria, et al.
Publicado: (2020)

Cutaneous metastasis of PD-L1 positive cervical carcinoma
por: Liu, Chrissy, et al.
Publicado: (2022)

PD-L1 expression in medulloblastoma: an evaluation by subgroup
por: Martin, Allison M., et al.
Publicado: (2018)

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
por: Orme, Jacob J, et al.
Publicado: (2020)

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
por: Han, Jiheun, et al.
Publicado: (2017)

α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets
por: Rothhammer, Veit, et al.
Publicado: (2014)

PD44 - In vitro fertilisation is positively associated with prevalence of asthma in childhood
por: Guibas, George V, et al.
Publicado: (2014)

PD43 - Body fat mass is positively associated with pediatric asthma
por: Guibas, George V, et al.
Publicado: (2014)

Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50%
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
por: Wartewig, Tim, et al.
Publicado: (2017)

Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review
por: Gasser, Thomas
Publicado: (2015)

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016)

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma
por: Shimizu, Akira, et al.
Publicado: (2016)

Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
por: Choo, Joan, et al.
Publicado: (2023)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
por: Mehnert, Janice M., et al.
Publicado: (2019)

PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials
por: Hong, Angela M, et al.
Publicado: (2016)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
por: Nascimento, Catarina, et al.
Publicado: (2020)

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement
por: Isla, Dolores, et al.
Publicado: (2023)

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
por: Elkrief, Arielle, et al.
Publicado: (2023)

Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice
por: Nishimura, Hiroyuki, et al.
Publicado: (2000)

Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease
por: Tiemann, Markus, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s0qio588a1m859hrs1jdimvt8n